Acquiring Company
Sudarshan Pharma Industries Ltd
Acquired Company
USFDA-approved manufacturing facility
Description
Sudarshan Pharma Industries Ltd has proposed the acquisition of a USFDA-approved manufacturing facility located in Visakhapatnam. The facility, which specializes in Active Pharmaceutical Ingredients, has significant operational capabilities and important regulatory certifications. This acquisition aims to enhance Sudarshan Pharma's production capacity and offer a broader range of pharmaceutical solutions. The company submitted details of the acquisition to the BSE on August 14, 2026.
Don't miss Sudarshan Pharma Industries Ltd's next move
Get an email the moment Sudarshan Pharma Industries Ltd makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired USFDA-approved manufacturing facility?
USFDA-approved manufacturing facility was acquired by Sudarshan Pharma Industries Ltd, based in Visakhapatnam. The deal was reported on August 14, 2026. Sudarshan Pharma Industries Ltd is a pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs). Sudarshan Pharma Industries Ltd is privately held and operates in Manufacturing.
When did Sudarshan Pharma Industries Ltd acquire USFDA-approved manufacturing facility?
Sudarshan Pharma Industries Ltd's acquisition of USFDA-approved manufacturing facility was reported on August 14, 2026. Sudarshan Pharma Industries Ltd has proposed the acquisition of a USFDA-approved manufacturing facility located in Visakhapatnam. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does USFDA-approved manufacturing facility do?
The USFDA-approved manufacturing facility specializes in producing Active Pharmaceutical Ingredients (APIs) and API intermediates. It is privately held, operating in Manufacturing, and is based in Visakhapatnam.